Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Hypofractionated Radiotherapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution.

Takahashi N, Matsushita H, Umezawa R, Yamamoto T, Ishikawa Y, Katagiri Y, Tasaka S, Takeda K, Fukui K, Kadoya N, Ito K, Jingu K.

Eur Thyroid J. 2019 Jan;8(1):24-30. doi: 10.1159/000493315. Epub 2018 Oct 4.

2.

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.

Matsushita H, Jingu K, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N, Katagiri Y, Kadoya N.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818803597. doi: 10.1177/1533033818803597. Review.

3.

Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.

Yamamoto T, Kadoya N, Morishita Y, Sato Y, Matsushita H, Umezawa R, Ishikawa Y, Takahashi N, Katagiri Y, Takeda K, Jingu K.

PLoS One. 2018 Oct 4;13(10):e0204734. doi: 10.1371/journal.pone.0204734. eCollection 2018.

4.

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.

Jingu K, Matsushita H, Yamamoto T, Umezawa R, Ishikawa Y, Takahashi N, Katagiri Y, Takeda K, Kadoya N.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794936. doi: 10.1177/1533033818794936.

5.

Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.

Yamamoto T, Kadoya N, Sato Y, Matsushita H, Umezawa R, Kubozono M, Ishikawa Y, Kozumi M, Takahashi N, Morishita Y, Katagiri Y, Sato K, Ito K, Takeda K, Jingu K.

Clin Lung Cancer. 2018 Jan;19(1):e85-e90. doi: 10.1016/j.cllc.2017.05.022. Epub 2017 Jun 8.

PMID:
28655592
6.

Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma.

Takeda K, Matsushita H, Kubozono M, Tanabe T, Ishikawa Y, Yamamoto T, Kozumi M, Takahashi N, Katagiri Y, Tasaka S, Fukui K, Takeda K, Fujishima F, Ichinose M, Jingu K.

Intern Med. 2016;55(22):3325-3330. Epub 2016 Nov 15.

7.

Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.

Takahashi N, Yamamoto T, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Ishikawa Y, Kozumi M, Katagiri Y, Tasaka S, Takeda K, Takeda K, Dobashi S, Jingu K.

J Radiat Res. 2016 Nov;57(6):655-661. Epub 2016 Jul 15.

8.

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.

Yamamoto T, Kadoya N, Takeda K, Matsushita H, Umezawa R, Sato K, Kubozono M, Ito K, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Onishi H, Jingu K.

Radiat Oncol. 2016 May 26;11:72. doi: 10.1186/s13014-016-0651-5.

9.

Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols.

Umezawa R, Jingu K, Matsushita H, Sugawara T, Kubozono M, Yamamoto T, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Kadoya N, Takeda K, Ariga H, Nemoto K, Yamada S.

BMC Cancer. 2015 Oct 27;15:813. doi: 10.1186/s12885-015-1836-2.

10.

Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan.

Jingu K, Umezawa R, Matsushita H, Sugawara T, Kubozono M, Yamamoto T, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Kadoya N, Takeda K.

Int J Clin Oncol. 2016 Apr;21(2):276-282. doi: 10.1007/s10147-015-0896-2. Epub 2015 Sep 1.

PMID:
26324841
11.

Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.

Yamamoto T, Kadoya N, Shirata Y, Koto M, Sato K, Matsushita H, Sugawara T, Umezawa R, Kubozono M, Ishikawa Y, Kozumi M, Takahashi N, Ito K, Katagiri Y, Takeda K, Jingu K.

Radiat Oncol. 2015 Feb 7;10:35. doi: 10.1186/s13014-015-0343-6.

12.

Aureobasidium pullulans culture supernatant significantly stimulates R-848-activated phagocytosis of PMA-induced THP-1 macrophages.

Tamegai H, Takada Y, Okabe M, Asada Y, Kusano K, Katagiri YU, Nagahara Y.

Immunopharmacol Immunotoxicol. 2013 Aug;35(4):455-61. doi: 10.3109/08923973.2013.800106. Epub 2013 Jun 21.

PMID:
23786444
13.

The human CD10 lacking an N-glycan at Asn(628) is deficient in surface expression and neutral endopeptidase activity.

Sato B, Katagiri YU, Iijima K, Yamada H, Ito S, Kawasaki N, Okita H, Fujimoto J, Kiyokawa N.

Biochim Biophys Acta. 2012 Nov;1820(11):1715-23. doi: 10.1016/j.bbagen.2012.06.017. Epub 2012 Jul 3.

PMID:
22766194
14.

Lipid rafts enriched in monosialylGb5Cer carrying the stage-specific embryonic antigen-4 epitope are involved in development of mouse preimplantation embryos at cleavage stage.

Sato B, Katagiri YU, Miyado K, Okino N, Ito M, Akutsu H, Okita H, Umezawa A, Fujimoto J, Toshimori K, Kiyokawa N.

BMC Dev Biol. 2011 Apr 14;11:22. doi: 10.1186/1471-213X-11-22.

15.

GalNAc╬▓1,3-linked paragloboside carries the epitope of a sperm maturation-related glycoprotein that is recognized by the monoclonal antibody MC121.

Katagiri YU, Sato B, Yamatoya K, Taki T, Goto-Inoue N, Setou M, Okita H, Fujimoto J, Ito C, Toshimori K, Kiyokawa N.

Biochem Biophys Res Commun. 2011 Mar 18;406(3):326-31. doi: 10.1016/j.bbrc.2011.02.019. Epub 2011 Feb 17.

PMID:
21303663
16.

Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer.

Ogasawara N, Katagiri YU, Kiyokawa N, Kaneko T, Sato B, Nakajima H, Miyagawa Y, Kushi Y, Ishida H, Kiso M, Okita H, Sato T, Fujimoto J.

J Biochem. 2011 Mar;149(3):321-30. doi: 10.1093/jb/mvq142. Epub 2010 Dec 8.

PMID:
21148159
17.

Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry.

Kaneko T, Okita H, Nakajima H, Iijima K, Ogasawara N, Miyagawa Y, Katagiri YU, Nakagawa A, Kiyokawa N, Sato T, Fujimoto J.

Int J Oncol. 2010 Nov;37(5):1279-88.

PMID:
20878075
18.

A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation.

Miyagawa Y, Okita H, Hiroyama M, Sakamoto R, Kobayashi M, Nakajima H, Katagiri YU, Fujimoto J, Hata J, Umezawa A, Kiyokawa N.

Tissue Eng Part A. 2011 Feb;17(3-4):513-21. doi: 10.1089/ten.TEA.2009.0810. Epub 2010 Oct 22.

PMID:
20818998
19.

Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.

Onda K, Iijima K, Katagiri YU, Okita H, Saito M, Shimizu T, Kiyokawa N.

Int J Hematol. 2010 Jun;91(5):808-19. doi: 10.1007/s12185-010-0567-z. Epub 2010 Apr 29.

PMID:
20428981
20.

Ex vivo expanded cord blood CD4 T lymphocytes exhibit a distinct expression profile of cytokine-related genes from those of peripheral blood origin.

Miyagawa Y, Kiyokawa N, Ochiai N, Imadome K, Horiuchi Y, Onda K, Yajima M, Nakamura H, Katagiri YU, Okita H, Morio T, Shimizu N, Fujimoto J, Fujiwara S.

Immunology. 2009 Nov;128(3):405-19. doi: 10.1111/j.1365-2567.2009.03122.x.

21.

Kinetics and effect of integrin expression on human CD34(+) cells during murine leukemia virus-derived retroviral transduction with recombinant fibronectin for stem cell gene therapy.

Horiuchi Y, Onodera M, Miyagawa Y, Sato B, Onda K, Katagiri YU, Okita H, Okada M, Otsu M, Kume A, Okuyama T, Fujimoto J, Kuratsuji T, Kiyokawa N.

Hum Gene Ther. 2009 Jul;20(7):777-83. doi: 10.1089/hum.2008.159.

PMID:
19284246
22.

EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells.

Miyagawa Y, Okita H, Itagaki M, Toyoda M, Katagiri YU, Fujimoto J, Hata J, Umezawa A, Kiyokawa N.

PLoS One. 2009;4(2):e4634. doi: 10.1371/journal.pone.0004634. Epub 2009 Feb 27.

23.

The expression of granulysin in systemic anaplastic large cell lymphoma in childhood.

Kitamura N, Katagiri YU, Itagaki M, Miyagawa Y, Onda K, Okita H, Mori A, Fujimoto J, Kiyokawa N.

Leuk Res. 2009 Jul;33(7):908-12. doi: 10.1016/j.leukres.2009.01.032. Epub 2009 Feb 24.

PMID:
19243819
24.

Human osteoblasts support hematopoietic cell development in vitro.

Shiozawa Y, Takenouchi H, Taguchi T, Saito M, Katagiri YU, Okita H, Shimizu T, Yamashiro Y, Fujimoto J, Kiyokawa N.

Acta Haematol. 2008;120(3):134-45. doi: 10.1159/000178144. Epub 2008 Nov 28.

PMID:
19039204
25.

B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells.

Saito Y, Miyagawa Y, Onda K, Nakajima H, Sato B, Horiuchi Y, Okita H, Katagiri YU, Saito M, Shimizu T, Fujimoto J, Kiyokawa N.

Immunology. 2008 Dec;125(4):570-90. doi: 10.1111/j.1365-2567.2008.02872.x. Epub 2008 Jun 6.

26.

Preferential localization of SSEA-4 in interfaces between blastomeres of mouse preimplantaion embryos.

Sato B, Katagiri YU, Miyado K, Akutsu H, Miyagawa Y, Horiuchi Y, Nakajima H, Okita H, Umezawa A, Hata J, Fujimoto J, Toshimori K, Kiyokawa N.

Biochem Biophys Res Commun. 2007 Dec 28;364(4):838-43. doi: 10.1016/j.bbrc.2007.10.093. Epub 2007 Oct 26.

PMID:
18273440
27.

Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.

Miyagawa Y, Okita H, Nakaijima H, Horiuchi Y, Sato B, Taguchi T, Toyoda M, Katagiri YU, Fujimoto J, Hata J, Umezawa A, Kiyokawa N.

Mol Cell Biol. 2008 Apr;28(7):2125-37. doi: 10.1128/MCB.00740-07. Epub 2008 Jan 22. Erratum in: Mol Cell Biol. 2008 Jun;28(11):3882.

28.

The detergent-insoluble microdomains, rafts, can be used as an effective immunogen.

Katagiri YU, Nakajima H, Sato B, Miyagawa Y, Horiuchi Y, Okita H, Fujimoto J, Kiyokawa N.

Glycoconj J. 2008 Aug;25(6):495-501. Epub 2007 Dec 11.

PMID:
18074225
29.

Interleukin-7 contributes to human pro-B-cell development in a mouse stromal cell-dependent culture system.

Taguchi T, Takenouchi H, Shiozawa Y, Matsui J, Kitamura N, Miyagawa Y, Katagiri YU, Takahashi T, Okita H, Fujimoto J, Kiyokawa N.

Exp Hematol. 2007 Sep;35(9):1398-407. Epub 2007 Jul 25.

PMID:
17656007
30.

Laminin binding protein, 34/67 laminin receptor, carries stage-specific embryonic antigen-4 epitope defined by monoclonal antibody Raft.2.

Katagiri YU, Kiyokawa N, Nakamura K, Takenouchi H, Taguchi T, Okita H, Umezawa A, Fujimoto J.

Biochem Biophys Res Commun. 2005 Jul 15;332(4):1004-11.

PMID:
15922307
31.

Dietary bioflavonoids induce apoptosis in human leukemia cells.

Matsui J, Kiyokawa N, Takenouchi H, Taguchi T, Suzuki K, Shiozawa Y, Saito M, Tang WR, Katagiri YU, Okita H, Fujimoto J.

Leuk Res. 2005 May;29(5):573-81. Epub 2005 Jan 19.

PMID:
15755510
32.

Development of novel monoclonal antibody 4G8 against swine leukocyte antigen class I alpha chain.

Tang WR, Kiyokawa N, Eguchi T, Matsui J, Takenouchi H, Honma D, Yasue H, Enosawa S, Mimori K, Itagaki M, Taguchi T, Katagiri YU, Okita H, Amemiya H, Fujimoto J.

Hybrid Hybridomics. 2004 Jun;23(3):187-91.

PMID:
15312310
33.

Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells.

Taguchi T, Kiyokawa N, Takenouch H, Matsui J, Tang WR, Nakajima H, Suzuki K, Shiozawa Y, Saito M, Katagiri YU, Takahashi T, Karasuyama H, Matsuo Y, Okita H, Fujimoto J.

Immunology. 2004 Aug;112(4):575-82.

34.

Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells.

Takenouchi H, Kiyokawa N, Taguchi T, Matsui J, Katagiri YU, Okita H, Okuda K, Fujimoto J.

J Cell Sci. 2004 Aug 1;117(Pt 17):3911-22. Epub 2004 Jul 20.

35.

Characterization of a shiga-toxin 1-resistant stock of vero cells.

Sekino T, Kiyokawa N, Taguchi T, Takenouchi H, Matsui J, Tang WR, Suzuki T, Nakajima H, Saito M, Ohmi K, Katagiri YU, Okita H, Nakao H, Takeda T, Fujimoto J.

Microbiol Immunol. 2004;48(5):377-87.

36.

Diagnostic importance of CD179a/b as markers of precursor B-cell lymphoblastic lymphoma.

Kiyokawa N, Sekino T, Matsui T, Takenouchi H, Mimori K, Tang WR, Matsui J, Taguchi T, Katagiri YU, Okita H, Matsuo Y, Karasuyama H, Fujimoto J.

Mod Pathol. 2004 Apr;17(4):423-9.

37.

Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.

Mimori K, Kiyokawa N, Taguchi T, Suzuki T, Sekino T, Nakajima H, Saito M, Katagiri YU, Isoyama K, Yamada K, Matsuo Y, Fujimoto J.

Leukemia. 2003 Jun;17(6):1164-74.

PMID:
12764385
38.

Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells.

Taguchi T, Kiyokawa N, Mimori K, Suzuki T, Sekino T, Nakajima H, Saito M, Katagiri YU, Matsuo N, Matsuo Y, Karasuyama H, Fujimoto J.

J Immunol. 2003 Jan 1;170(1):252-60.

39.
40.

Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion.

Saito M, Kiyokawa N, Taguchi T, Suzuki K, Sekino T, Mimori K, Suzuki T, Nakajima H, Katagiri YU, Fujimura J, Fujita H, Ishimoto K, Yamashiro Y, Fujimoto J.

Exp Hematol. 2002 Oct;30(10):1115-23.

PMID:
12384141
41.

Rum1, an inhibitor of cyclin-dependent kinase in fission yeast, is negatively regulated by mitogen-activated protein kinase-mediated phosphorylation at Ser and Thr residues.

Matsuoka K, Kiyokawa N, Taguchi T, Matsui J, Suzuki T, Mimori K, Nakajima H, Takenouchi H, Weiran T, Katagiri YU, Fujimoto J.

Eur J Biochem. 2002 Jul;269(14):3511-21.

42.

Nitrobenzylthioinosine (NBT), a nucleoside transport inhibitor, protects against Shiga toxin cytotoxicity in human microvascular endothelial cells.

Ohmi K, Kiyokawa N, Sekino T, Suzuki T, Mimori K, Taguchi T, Nakajima H, Katagiri YU, Fujimoto J, Nakao H, Takeda T.

Endothelium. 2001;8(4):261-8.

PMID:
11824478
44.

Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance.

Nakajima H, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Mimori K, Ebata T, Saito M, Nakao H, Takeda T, Fujimoto J.

J Biol Chem. 2001 Nov 16;276(46):42915-22. Epub 2001 Sep 13.

45.

Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.

Nakajima H, Katagiri YU, Kiyokawa N, Taguchi T, Suzuki T, Sekino T, Mimori K, Saito M, Nakao H, Takeda T, Fujimoto J.

Protein Expr Purif. 2001 Jul;22(2):267-75.

PMID:
11437603
46.

CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system.

Suzuki T, Kiyokawa N, Taguchi T, Sekino T, Katagiri YU, Fujimoto J.

J Immunol. 2001 May 1;166(9):5567-77.

47.

A role for lipid rafts in immune cell signaling.

Katagiri YU, Kiyokawa N, Fujimoto J.

Microbiol Immunol. 2001;45(1):1-8. Review.

48.

Activation of the caspase cascade during Stx1-induced apoptosis in Burkitt's lymphoma cells.

Kiyokawa N, Mori T, Taguchi T, Saito M, Mimori K, Suzuki T, Sekino T, Sato N, Nakajima H, Katagiri YU, Takeda T, Fujimoto J.

J Cell Biochem. 2001;81(1):128-42.

PMID:
11180403
49.

Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells.

Mori T, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Sato N, Ohmi K, Nakajima H, Takeda T, Fujimoto J.

Exp Hematol. 2000 Nov;28(11):1260-8.

PMID:
11063874
50.

Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains.

Katagiri YU, Mori T, Nakajima H, Katagiri C, Taguchi T, Takeda T, Kiyokawa N, Fujimoto J.

J Biol Chem. 1999 Dec 3;274(49):35278-82. Erratum in: J Biol Chem 2000 Jun 9;275(23):17916.

Supplemental Content

Loading ...
Support Center